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Functional redundancy 
of Burkholderia pseudomallei 
phospholipase C enzymes and their 
role in virulence
Varintip Srinon1,2,6, Patoo Withatanung1,6, Somjit Chaiwattanarungruengpaisan3, 
Metawee Thongdee3, Chatruthai Meethai1, Joanne M. Stevens4, Richard W. Titball5 & 
Sunee Korbsrisate1*
Phospholipase C (PLC) enzymes are key virulence factors in several pathogenic bacteria. Burkholderia 
pseudomallei, the causative agent of melioidosis, possesses at least three plc genes (plc1, plc2 and 
plc3). We found that in culture medium plc1 gene expression increased with increasing pH, whilst 
expression of the plc3 gene was pH (4.5 to 9.0) independent. Expression of the plc2 gene was not 
detected in culture medium. All three plc genes were expressed during macrophage infection by B. 
pseudomallei K96243. Comparing B. pseudomallei wild-type with plc mutants revealed that plc2, 
plc12 or plc123 mutants showed reduced intracellular survival in macrophages and reduced plaque 
formation in HeLa cells. However, plc1 or plc3 mutants showed no significant differences in plaque 
formation compared to wild-type bacteria. These findings suggest that Plc2, but not Plc1 or Plc3 
are required for infection of host cells. In Galleria mellonella, plc1, plc2 or plc3 mutants were not 
attenuated compared to the wild-type strain, but multiple plc mutants showed reduced virulence. 
These findings indicate functional redundancy of the B. pseudomallei phospholipases in virulence.
Burkholderia pseudomallei, a Gram-negative facultative intracellular bacterium, is the etiological agent of meli-
oidosis in humans and in animals. Melioidosis in humans was at one time thought to be largely restricted to 
Southeast Asia and Northern Australia, but it is now thought to occur in many tropical and sub-tropical regions 
of the  world1. The annual global burden of meliodosis is estimated to be 165,000 cases with 89,000 deaths from 
the  disease1. A feature of B. pseudomallei is its ability to modulate a range of host-cell responses and to evade 
phagocyte killing  activity2,3. B. pseudomallei has evolved mechanisms to evade phagocyte activities, including 
escape from phagosomes and entry into host cell cytosol where it multiplies and forms actin tails allowing cell-to-
cell  spreading4. This complex intracellular lifestyle is contributed by several bacterial virulence factors including 
type three secretion systems (T3SS), type six secretion systems (T6SS), polysaccharide capsule, lipopolysaccharide 
(LPS), and various secreted effector  proteins5. Additionally, B. pseudomallei can produce many enzymes which 
play roles in virulence including proteases, catalase, peroxidase, superoxide  dismutase1, and phospholipase C 
(Plc)  enzymes6. Plc enzymes play roles in the pathogenesis of several Gram-positive and Gram-negative bacte-
rial infections including those caused by Mycobacterium tuberculosis7, Pseudomonas aeruginosa8, Clostridium 
perfringens9, Listeria monocytogenes10, and Legionella pneumophila11. Also, different of Plcs play different roles in 
 virulence12, including tissue colonization, evasion of host defense mechanisms, escape from host cell phagosomes 
and/or the induction of mediators of  inflammation13.
Analysis of the B. pseudomallei K96243 genome reveals genes encoding three Plc enzymes (Plc1, Plc2 and 
Plc3). The genes encoding Plc1 (bpsl2403) and Plc2 (bpsl0338) are located on chromosome 1. These encoded 
proteins are predicted to be acidic, have the ability to hydrolyze phospholipids including phosphatidylcholine 
and sphingomyelin and are non-hemolytic14. The gene encoding Plc3 (bpss0067) is located on chromosome  25. 
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At present, the conditions under which the plc genes are expressed, and their roles in virulence are poorly under-
stood. We have previously characterized the B. pseudomallei Plc1 and Plc2 and found that Plc2 was  cytotoxic14. 
Additionally, these Plc enzymes appear to play a role in nutrient  acquisition14. Subsequently, Burtnick et al.15 
showed that B. pseudomallei Plc1 and Plc2 are secreted from the bacterial cell via the type II secretion system 
(T2SS) in a GspD-dependent  manner15.
Little is known about the B. pseudomallei Plc3 enzyme. Whole-genome microarrays have revealed that plc3 is 
up-regulated in vivo, and in hamsters a plc3 mutant shows reduced virulence compared to the wild-type, suggest-
ing that it is required for  virulence16. However, the mechanisms underlying attenuation are unknown. Dowling 
et al.17 reported that Plc3 might be a potential candidate vaccine requiring further study.
In this study, the expression of the plc genes in culture medium and in J774A.1 macrophage-like cells was 
analyzed using RT-PCR. B. pseudomallei plc1, plc2 or plc3 single mutants and plc12 or plc123 mutants were 
assessed for virulence in macrophages and in Galleria mellonella larvae. Our work provides new insights into 
the role of Plc enzymes in the pathogenesis of disease caused by B. pseudomallei.
Results and discussion
Culture pH differentially affects plc1 gene expression. B. pseudomallei is an intracellular bacterium. 
After phagocytosis by phagocytes, the bacteria encounter acidic condition within the phagosome, before escap-
ing to survive in the  cytosol4. To determine the effect of pH on the expression of the plc1-3 genes, B. pseudomallei 
K96243 was incubated in LB broth which had been adjusted to pH 4.5, 5.0, 7.0, 8.0 or 9.0 before bacterial mRNA 
was extracted and tested. Using RT-PCR we first showed that expression of B. pseudomallei 23S rRNA was simi-
lar at all pH conditions tested. RT-PCR revealed that the level of transcription of the plc1 gene increased between 
pH 4.5 and 9.0. This result suggests that the pH of bacterial cultures can differentially affect B. pseudomallei plc1 
gene expression. In contrast, the level of expression of plc3 was similar at all pH values tested. Expression of the 
plc2 gene was not detected under any of the conditions tested (Fig. 1a) (full-length gels are presented in Sup-
plementary Fig. 1). Our finding that plc2 was not expressed in strain K96243 is similar to the results reported 
by Ooi et al.18. However, plc2 is expressed in B. pseudomallei strain  2218, and the Plc2 protein was detected in B. 
pseudomallei strain  MSHR66815 culture supernatant. These findings indicate that plc2 gene expression is strain-
dependent.
The B. pseudomallei plc genes are induced in infected macrophages. We next investigated expres-
sion of the plc genes in macrophages. J774A.1 macrophage-like cells were infected with B. pseudomallei K96243. 
At 2, 4, and 6 h post-infection (p.i.), the cells were lysed, and mRNAs corresponding to the plc gene detected 
using RT-PCR. The results showed no expression of the plc1, plc2 or plc3 genes at 2 h p.i. The expression of all 
of the plc genes was detected at 4 h p.i., but the level of expression of plc2 was relatively higher than the levels 
of expression of plc1 and plc3. At 6 h p.i., the levels of expression of all plc genes increased compared with 4 p.i. 
(Fig. 1b). Our finding that the expression of plc2 gene was induced in macrophages, even though we could not 
detect expression in culture medium (Fig. 1a), suggests a role of Plc2 in the infection of macrophages.
We stained infected macrophages for LAMP-1 and B. pseudomallei using probes labelled with Alexa Fluor 
488 or Alexa Fluor 568 and nuclei were stained with DAPI (Fig. 1c). This revealed that at 2 h p.i. most B. pseu-
domallei K96243 were trapped within the phagosome. However, at 4 h p.i, co-localization of B. pseudomallei 
with lysosomes was rare indicating bacterial escape from phagosomes, and almost all of the B. pseudomallei 
cells were not associated with the phagosome at 6 h p.i. It is possible that the intracellular environment induces 
expression of plc1, plc2 and plc3 genes.
Several previous reports show the expression of plc genes of other species of bacteria in host  tissues12,13. For 
example, the Mycobacterium tuberculosis plc genes are up-regulated in macrophages, and the Plcs are cytotoxic 
to mouse  macrophages7,19. The Clostridium perfringens PLC (α-toxin) is produced in host tissues and can activate 
the arachidonic acid cascade in cells, with consequent modulation of host immune  responses20, and the induction 
of ERK1/2 pathway, resulting in  cytotoxicity21.
B. pseudomallei plc2, but not plc1 or plc3, is required for bacterial survival and replication in 
macrophages. To provide insight into the role of plc1, plc2 and plc3 genes in virulence, we tested a range 
of single and multiple mutants. We have previously constructed plc1, plc2 and plc12  mutants14 and these were 
included in our study. Additionally, for this study we constructed plc3 single and plc123 mutants by insertion 
 mutagenesis14. Mutagenesis of the plc genes was confirmed by Southern blotting (data not shown). J774A.1 mac-
rophage-like cells were infected with the mutants. At 2, 4, 6 and 8 h p.i., the numbers of recoverable plc2, plc12 or 
plc123 mutants were significantly lower (*P < 0.05, **P < 0.01, ***P < 0.001) than the number of viable wild-type 
bacteria (Fig. 2). In contrast, there was no significant difference (P > 0.05) in the numbers of viable single plc1 
or plc3 mutants compared with the number of viable wild-type bacteria at all tested time points (2, 4, 6 or 8 h 
p.i.). These findings indicate that plc2 gene was required for B. pseudomallei survival and replication inside the 
macrophage. Our results also indicate that plc1 and plc3 play no role in survival and replication in macrophages, 
but we cannot discount the possibility of functional redundancy between these enzymes, which would mask the 
phenotype associated with the single plc1 and plc3 mutants.
To investigate whether the phenotypes we observed with the plc mutants was due to polar effects on down-
stream genes we measured expression of the genes downstream of plc1, plc2 or plc3 (bpsl2404, bpsl0337 or 
bpss0068 respectively) using RT-PCR. B. pseudomallei wild-type and the plc mutants were cultured in LB broth, 
or extracted from intracellular bacteria after macrophage infection. We demonstrated similar bpsl2404, bpsl0337 
and bpss0068 amplicons with mRNA from wild-type or plc1, plc2, or plc3 mutants cultured in LB broth (Fig. 3a) 
and extracted from intracellular bacteria (Fig. 3b) (full-length gels are presented in Supplementary Fig. 2). 
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Figure 1.  Reverse transcription (RT)-PCR analysis of B. pseudomallei plc expression. (a) Expression of plc 
genes in LB broth adjusted to pH 4.5, 5, 7, 8 or 9. B. pseudomallei wild-type K96243 was incubated for 15 min 
in LB broth at the pH indicated before RNA extraction. Positive control (+ ve) was B. pseudomallei genomic 
DNA. DNase-treated bacterial RNA was used as a negative control (− ve) to confirm the absence of DNA 
contamination in RNA samples (full-length gels are presented in Supplementary Fig. 1). (b) Expression of plc 
genes in J774A.1 macrophage-like cells infected with B. pseudomallei. RNA of B. pseudomallei K96243 was 
harvested from infected macrophages at 2, 4 or 6 h p.i. and converted to cDNA for PCR analysis with primers 
specific to each plc gene. Positive control (+ ve) was B. pseudomallei genomic DNA. DNase-treated bacterial 
RNA was used as a negative control (−ve). Unfortunately we are not able to reproduce the full length image 
of this gel because this image file was inadvertently deleted after this project was completed and before we 
submitted this manuscript. (c) Confocal micrographs of J774A.1 macrophages infected with B. pseudomallei 
(MOI 10) showed that majority of B. pseudomallei were within phagosomes at 2 h post-infection (p.i.). Escape of 
bacteria from the vacuoles was first observed at 4 h p.i., and most bacteria were within the cytosol at 6 h p.i.
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These results indicate that the insertional mutation in the plc1, plc2, or plc3 genes did not abolish the expression 
of downstream genes. However, we cannot discount the possibility that expression of downstream genes was 
affected.
The defect in intracellular survival of the plc2 mutant is not due to delayed escape from the 
phagolysosome. The ability of B. pseudomallei to escape from the phagosome thought to be considered 
to be a mechanism by which the bacteria evade phagocyte killing. We had already showed that the plc1, plc2 
and plc3 genes are expressed in macrophages (Fig. 1c) and that the B. pseudomallei plc2 mutant was defective 
in survival in macrophages (Fig. 2). Here we investigated whether Plc2 enzyme played a role in escape from the 
phagolyosome. J774A.1 macrophage-like cells were infected with either B. pseudomallei wild-type, plc2, plc12, or 
plc123 mutants, and co-localization with lysosomes at 3 h p.i. was investigated by immunostaining with antibod-
ies specific to LAMP-1. A B. pseudomallei bipB mutant, which is known to be delayed in phagosome  escape22,23, 
was included as a control in our experiments. As expected, we found that the majority of bipB mutant cells 
showed delayed escape from phagosome as evidence the increased association with LAMP-1 (86 ± 3.3% associa-
tion) when compared with the wild-type bacteria (Fig. 4a). The B. pseudomallei plc2, plc12 and plc123 mutants 
rarely co-localized with LAMP-1 (20.3 ± 1.2%, 20.7 ± 2.3%, and 27.3 ± 3.5% co-localization, respectively; Fig. 4b), 
similar to the degree of co-localization of the wild-type bacteria with LAMP-1 (17.7 ± 1.5% co-localization). This 
finding suggests that mutation of the plc genes did not affect escape of B. pseudomallei from phagosome.
B. pseudomallei plc2 mutant shows deficiency in plaque formation. We next measured plaque 
formation in monolayers of HeLa cells infected with either B. pseudomallei wild-type or the plc1 plc2, plc3, plc12 
or plc123 mutants. Plaque-formation reflects the ability of bacteria to invade, survive within and then spread 
from cell to cell. As shown in Fig. 5, plaque-formation in HeLa cells was significantly reduced in cells infected 
with the plc2, plc12 or plc123 mutants, compared to the wild-type strain (**P < 0.01, ***P < 0.001, ***P < 0.001, 
respectively). In contrast, there was no significant reduction in plaque formation after infection with the plc1 
or plc3 mutants (P > 0 0.05) (Fig. 5). This result shows correlation with our previous  study14 which showed that 
plaque-formation efficiency in HeLa cells was significantly reduced after infection with plc2 or plc12 double 
mutants compared to the wild-type strain. Plaque-formation was restored in a plc2 complemented strain. This 
finding suggested that the defective phenotype was due to the plc2 gene  mutation14. However, complementation 
of plc12 double and plc123 triple mutants was not possible because of restrictions on the use of multiple antibi-
otic resistance markers in B. pseudomallei.
Figure 2.  Intracellular growth of B. pseudomallei wild-type or plc mutants in J774A.1 macrophage-like cells. 
B. pseudomallei wild-type, plc1, plc2, plc3, plc12 or plc123 mutants were used to infect J774A.1 cells at an MOI 
of 0.5. At 2, 4, 6 or 8 h p.i., the infected cells were lysed and bacteria enumerated after plating onto agar. Error 
bars represent standard error of mean for data collected from 3 independent experiments. Asterisks indicate 
significant differences (*P < 0.05, **P < 0.01, and ***P < 0.001, one-way ANOVA followed by Dunnett’s post hoc 
test) between B. pseudomallei wild-type K96243 and mutant strains. The figure was prepared using GraphPad 
Prism version 7.05 for Windows (www.graph pad.com).
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To assess whether the reduction in plaque formation reflects a reduced ability to adhere to or to invade HeLa 
cells, we assessed invasion efficiency. There was no significant difference (P > 0 0.05) in the number of culturable 
intracellular bacteria at 2 h p.i. between wild-type and either plc2, plc12 double, or plc123 triple mutants (Fig. 6). 
This finding indicates that the absence of the plc 2 gene had no effect of the bacteria to adhere to or invade HeLa 
cells. Overall, our findings indicate that Plc2 is required for survival and replication of B. pseudomallei in non-
phagocytic cells.
The plc12 and plc123 mutants are attenuated in G. mellonella. Our results above showed that Plc2 
was required for intracellular survival and replication in host cells. To investigate the roles of Plc1, Plc2 and Plc3 
in virulence of B. pseudomallei, a G. mellonella larvae infection model was  used24.
There was no significant difference (P > 0 0.05) in the survival of larvae infected with the plc1, plc2 or plc3 
mutants compared with the wild-type strain (Fig. 7). However, larvae infected with the plc12 or plc123 mutants 
showed significantly (P = 0.0031, P = 0.0018. respectively) increased survival, compared to larvae infected with 
the wild-type strain. This finding suggests redundancy of the functions of the phospholipases in virulence of B. 
pseudomallei. Our finding that there was no significant difference (P > 0 0.05) in the survival of larvae infected 
with the plc12 and plc123 mutants suggests that plc3 does not contribute to virulence in G. mellonella larvae. 
Because of the restrictions on the number of antibiotic markers we could introduce into B. pseudomallei, we 
could not generate plc12 or plc123 complemented mutants further validate our findings.
Our finding contrasts with a previous study where a plc3 mutant was found to  104-fold attenuated Syrian 
hamsters compared to the wild-type  bacterium16. This might reflect differences in the immune system between 
G. mellonella and mammals. G. mellonella possess an innate immune system which involves a cellular immune 
response mediated by hemocytes, and a humoral immune response orchestrated by antimicrobial  peptides25, 
However, they lack the complement system found in mammals and G. mellonella also lacks an adaptive immune 
 system26. Additionally, it is known that B. pseudomallei infection of hamsters is not similar to infection of other 
mammals such as mice. Hamsters are highly susceptible to infection with B. pseudomallei whereas mice are 
relatively  resistant27. There are also reports of the different behaviour of B. pseudomallei mutants in hamsters 
and in mice. For example fliC28 and fliD16 mutants are not attenuated in hamsters but a fliC mutant is highly 
attenuated in  mice29.
Figure 3.  Expression of genes downstream of plc1, plc2 or plc3, assessed using RT-PCR. The mRNA from 
wild-type, plc1, plc2, plc3, plc12, or plc123 mutants cultured in LB broth (a), or isolated from infected J774A.1 
macrophages (b) was extracted before converting to cDNA as outlined in material and methods (full-length gels 
are presented in Supplementary Fig. 2). The cDNA was amplified using PCR primers specific to the bpsl2404, 
bpsl0337 or bpss0068 genes which are downstream of plc1, plc2 or plc3, respectively (upper panel). The 16S 
rRNA (middle panel) and DNase-treated mRNA (lower panel) were included as a normalization control and 
negative control, respectively.
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Conclusion
The genes encoding three B. pseudomallei Plc enzymes are expressed within macrophage-like cells, but at different 
expression levels. The plc2 gene was expressed in infected macrophages but not in culture medium, suggesting a 
role in virulence. Our findings suggest that plc2 either alone, or in combination with plc1 and plc3, contributes 
to growth in host cells and our finding that virulence in G. mellonella was dependent on the inactivation of 
genes encoding combinations of Plc enzymes, indicates functional redundancy. The data reported in this study 
provide important new insight into the roles of Plcs in virulence of B. pseudomallei and open new opportunities 
for further research into the roles on these enzymes in virulence.
Materials and methods
Primers, bacterial strains and cell lines. Primers used in this study are shown in Table 1. Escherichia 
coli, B. pseudomallei K96243 and the mutant strains were routinely cultured in Luria–Bertani (LB) or trypticase 
soy medium. B. pseudomallei K96243 plc1, plc2 single and plc12 double mutants were constructed in the previ-
ous  study14. All cultures were typically grown for 24–48 h at 37 °C. Appropriate antibiotics (Sigma-Aldrich) i.e. 
chloramphenicol 50 µg/mL, kanamycin 400 µg/mL and tetracycline 50 µg/mL were added into the medium if 
required. All manipulations of B. pseudomallei were approved by the Technical Biosafety Committee (TBC), 
National Center for Genetic Engineering and Biotechnology (BIOTEC).
J774A.1 murine macrophage-like and human epithelial HeLa cells were obtained from the American Type 
Culture Collection (ATCC) and were cultured in Dulbecco’s Modified Eagle medium supplemented with 10% 
(v/v) heat-inactivated fetal bovine serum (Invitrogen) under a 5%  CO2 atmosphere at 37 °C in a humidified 
incubator.
RNA preparation and reverse transcription (RT)-PCR analysis. B. pseudomallei K96243 was grown 
in LB broth for 6 h before incubation at 37 °C for 15 min in LB broth pH 4.5, 5.0, 6.0, 7.0, 8.0 or 9.0. Total RNA 
was extracted from  108 CFUs B. pseudomallei cultured in each condition using TRIZOL (Invitrogen) according 
to manufacturer’s instructions. The isolated bacterial RNA was then treated with DNase I (Ambion) to remove 
any genomic DNA contamination before use.
To detect B. pseudomallei genes expression within macrophages, monolayers of J774A.1 murine macrophage-
like cells were infected with the bacteria. At the indicated time points, the infected cell monolayers were washed 
and subsequently lysed with 500 μL of 0.1% Triton X-100 (Sigma-Aldrich) to allow intracellular bacteria released 
from infected cells. Then, 500 μL of 1 × PBS was added and the intracellular bacterial RNA were extracted using 
TRIZOL (Invitrogen) according to manufacturer’s instructions.
To convert the extracted total RNA to cDNA, SuperScript III First-Strand Synthesis System (Invitrogen) was 
used. The cDNA was quantified and adjusted so that similar quantities were included in the PCR reactions. The 
cDNA was amplified using the PCR with primers (Table 1), GoTaq DNA polymerase (Promega) and cycling con-
ditions of 94 °C, 3 min and 30 cycles of 94 °C for 30 s, 50 °C for 1 min, and 72 °C for 45 s, followed by incubation 
at 72 °C for 5 min. In each PCR experiment, the amplification of 23S rRNA was used as a normalization control.
Construction of B. pseudomallei plc3 single and plc123 triple mutants. A B. pseudomallei plc3 
mutant was constructed by insertion  mutagenesis30. A 406-bp (nucleotide positions 1052–1457) internal region 
of the plc3 gene was amplified from B. pseudomallei K96243 genomic DNA with primers PLC88 and PLC89 
(Table 1). The amplified DNA fragment was ligated into EcoRV digested pKNOCK-Cm, a suicide  vector30 to 
generate recombinant plasmid pVSK3 for insertion mutagenesis. The constructed plc3 mutant was selected on 
Pseudomonas agar base supplemented with SR103E (Oxoid) and chloramphenicol.
To construct the B. pseudomallei plc123 triple mutant, the amplified internal plc3 fragment (nucleotide posi-
tions 1052-1457) was ligated into EcoRV digested pKNOCK-Km30. This constructed plasmid, designated pVSK4, 
was introduced into B. pseudomallei plc12 double  mutant14. The mutants were selected on Pseudomonas agar 
base (Oxoid) supplemented with SR103E (Oxoid) containing chloramphenicol, kanamycin and tetracycline 
(Sigma-Aldrich). The plc123 mutant was verified by PCR and Southern blotting.
Figure 4.  Quantitative analysis of bacterial co-localization with LAMP-1 in J774A.1 macrophage-like cells. 
(a) J774A.1 cells were infected with B. pseudomallei wild-type K96243, plc2, plc12, plc123 or bipB mutants for 
3 h. Cells were fixed, permeabilized and immunostained with rat anti-LAMP1 and mouse anti-Burkholderia 
monoclonal antibodies. The y-axis shows the number of bacteria co-localizing with LAMP-1 × 100/total number 
of intracellular bacteria. Error bars represent standard error of the mean for data collected from 3 independent 
experiments. Asterisks indicate significant differences (P < 0.01, students t-test) between B. pseudomallei wild-
type K96243 and mutants. The figure was prepared using GraphPad Prism version 7.05 for Windows (www.
graph pad.com). (b) Representative confocal micrographs of the association of B. pseudomallei with endocytic 
vesicles in J774A.1 cells. B. pseudomallei wild-type K96243, plc2, plc12 double, plc123 triple or bipB mutants 
were used to infect J774A.1 cells. At 3 h p.i., the infected macrophages and the bacteria were stained and 
visualised using confocal microscopy. Macrophage LAMP-1 was stained green with rat monoclonal antibody 
(1D4B) and Alexa Fluor 488 goat anti-rat IgG antibody, and nuclei were stained blue with DAPI. Bacteria were 
stained red with mouse anti-B. pseudomallei monoclonal antibody (9D5) and Alexa Fluor 568 goat anti-mouse 
IgG antibody. White arrows indicated the co-localization of B. pseudomallei and LAMP-1.
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Intracellular survival and plaque assays. Intracellular replication of B. pseudomallei in macrophage-
like cells was assessed as described  previously31 with some modifications. Briefly, J774A.1 murine macrophage-
like cells were seeded at a density of 2.5 × 105 cells per well of a 24-well tissue culture plate and infected approxi-
mately 24  h later with B. pseudomallei wild-type K96243 or plc mutant at a multiplicity of infection (MOI) 
of approximately 0.5, for 2 h. Then infected cells were overlaid with DMEM medium (Invitrogen) containing 
gentamicin 128 μg/mL and spectinomycin 256 μg/mL (Sigma-Aldrich) to kill extracellular bacteria. The infected 
cell monolayers were subsequently lysed at 2, 4, 6 and 8 h p.i. with 0.1% Triton X-100 (Sigma-Aldrich). The num-
bers of intracellular bacteria were quantified by serial dilution and plating on tryptic soy agar. Bacterial colony 
Figure 5.  Plaque-forming efficiencies of B. pseudomallei wild-type or plc mutants in HeLa cells. (a) 
Representative images of plaques. (b) Plaque-forming efficiency of either B. pseudomallei wild-type K96243, 
plc1, plc2, plc3, plc12 or plc123 mutants in HeLa cells infected at an MOI of 10. Plaques were visualized by crystal 
violet staining of the monolayers at 24 h p.i. Error bars represent standard error of the mean for data collected 
in 3 independent experiments. Asterisks indicate significant differences (**P < 0.01, and ***P < 0.001, one-way 
ANOVA followed by Dunnett’s post hoc test) between B. pseudomallei wild-type K96243 and mutant strains. 
The figure was prepared using GraphPad Prism version 7.05 for Windows (www.graph pad.com).
9
Vol.:(0123456789)
Scientific Reports |        (2020) 10:19242  | https://doi.org/10.1038/s41598-020-76186-z
www.nature.com/scientificreports/
forming units (CFU) were counted after 36–48 h of incubation at 37 °C. Plaque forming assays were performed 
as described  previously32. The plaque-forming efficiency was calculated as the number of plaques/bacterial CFU 
added per well.
Confocal analysis of bacterial co-localization with LAMP-1. The intracellular localizations of B. 
pseudomallei wild-type K96243 and the plc mutants in J774A.1 macrophages cells relative to LAMP-1 contain-
ing vesicles were investigated according to previously  described33. Briefly, Macrophages were infected for 2 h at 
a multiplicity of infection (MOI) of 2 and incubated at 37 °C, 5%  CO2. At different time points, B. pseudomallei 
infected J774A.1 cells were fixed in 4% paraformaldehyde, the monolayers were permeabilized with 0.5% (v/v) 
Figure 6.  Invasion efficiency of B. pseudomallei wild-type and plc mutants in HeLa cells. The B. pseudomallei 
wild-type, plc2, plc12 or plc123 mutants were used to infect HeLa cells at an MOI of 50. At 2 h p.i., the infected 
cells were lysed and the numbers of intracellular bacteria were enumerated by colony count. Error bars represent 
standard error of mean for data collected from 3 independent experiments. No significant difference between 
B. pseudomallei wild-type K96243 and mutant strains was detected (P > 0.05, one-way ANOVA followed by 
Dunnett’s post hoc test). The figure was prepared using GraphPad Prism version 7.05 for Windows (www.graph 
pad.com).
Figure 7.  Virulence of B. pseudomallei strains in G. mellonella larvae. Groups of 10 larvae were challenged with 
 102 CFU of B. pseudomallei wild-type, plc1, plc2, plc3, plc12 or plc123 mutants. The number of dead larvae was 
scored at 24, 28, 32 and 36 h p.i.. GraphPad Prism version 7.05 for Windows (www.graph pad.com) was used 
to graph and analyze the data using a Log-rank (Mantel-Cox) test. Asterisks indicate significant differences 
(P < 0.05), between B. pseudomallei wild-type K96243 and mutant strains. The figure was prepared using 
GraphPad Prism version 7.05 for Windows (www.graph pad.com).
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Triton X-100, and blocked with 1% (w/v) bovine serum albumin. Bacteria were detected with a 1:10 dilution 
of mouse anti-Burkholderia monoclonal antibody and detected with a 1:200 dilution of Alexa Fluor 568-goat 
anti-mouse IgG (Invitrogen, USA). LAMP1 was stained green with a 1:100 dilution of rat monoclonal antibody 
(1D4B; Abcam, USA) and 1:500 Alexa Fluor 488 goat anti-rat IgG antibody (Molecular Probes, USA), and nuclei 
were stained blue with a 1:500 dilution of 4,6-diamidino-2-phenylindole (DAPI). Cells were examined by a laser-
scanning confocal microscope equipped with LSM5 Image Browser (LSM 510 META, Carl Zeiss, Germany). The 
association of Burkholderia with LAMP1 was considered when the red fluorescent bacteria co-localized with the 
green fluorescence of LAMP1-positive vacuoles, represented as an area of yellow staining.
The percentage of intracellular Burkholderia associated with LAMP-1 was determined as the number of 
bacteria co-localized with LAMP-1/total number of intracellular bacteria × 100. For the quantitative analysis of 
the association of intracellular B. pseudomallei strains with LAMP-1 containing vesicles, at least 200 individual 
bacteria associated LAMP-1 containing vesicles were monitored.
Virulence in G. mellonella. Virulence in G. mellonella larvae was tested as described  previously24 with 
some modifications. Larvae between 2–2.5  cm and free of melanization or injury were used in the experi-
ments. To prepare the bacterial culture for infection, the overnight cultures of B. pseudomallei wild-type and the 
mutants were adjusted to a concentration of  104 CFUs per ml in PBS. A 701 N fixed needle syringe (Hamilton, 
Nevada) was used to inject 10 µl aliquots of the bacterial suspension into the G. mellonella larvae to get the final 
concentration of  102 CFUs. Injections were performed directly into the larval body cavity and groups of 10 larvae 
were injected with each bacterial strain. Control larvae were injected with PBS. Following injection, larvae were 
incubated in the dark at 37 °C and the number of dead larvae were recorded at a variety of times post injection. 
The Galleria mellonella study was approved by the Mahidol University-Institute Animal Care and Use Commit-
tee (U1-05763-2559).
Statistical analysis. For in vivo mutant characterization, a log-rank (Mantel-Cox) test was used to com-
pare survival curves and the experiments for comparison between groups were performed using the one-way 
ANOVA followed by Dunnett’s post hoc test within the GraphPad Prism version 7.05 for Windows (www.
graph pad.com, GraphPad Software, CA, USA). P-values less than 0.05 were considered statistically significant 
(*P < 0.05, **P < 0.01, and ***P < 0.001).
Received: 24 March 2020; Accepted: 21 October 2020
References
 1. Limmathurotsakul, D. et al. Predicted global distribution of Burkholderia pseudomallei and burden of melioidosis. Nat. Microbiol. 
1, 15008 (2016).
 2. Cheng, A. C. & Currie, B. J. Melioidosis: epidemiology, pathophysiology, and management. Clin. Microbiol. Rev. 18, 383–416 
(2005).
 3. White, N. J. Melioidosis. Lancet 361, 1715–1722 (2003).
Table 1.  Oligonucleotide primers used in this study.
Primers Oligonucleotide sequences (5′–3′) Purposes Sources
PLC88 AGA CCG TGC TGC TCG TGA A Forward primer for construction of plc3 mutant This study
PLC89 GGC TCG TTG TTC GGT CGC A Reverse primer for construction of plc3 mutant This study
Plc1F TGA TGC AGG AAA ACC GCT C Forward primer for internal fragment of plc1 gene This study
Plc1R AGC CCG TCC ACA TGT AGT AG Reverse primer for internal fragment of plc1 gene This study
Plc2F GCT CGA CAA CAG CGA TTA CG Forward primer for internal fragment of plc2 gene This study
Plc2R TTC TGC AGG ATG TTC GTC CC Reverse primer for internal fragment of plc2 gene This study
Plc3F TCA AGG AAG ACA TCC GTG CG Forward primer for internal fragment of plc3 gene This study
Plc3R CGT CGA AAT TCA CGA GCA GC Reverse primer for internal fragment of plc3 gene This study
23s F TTT CCC GCT TAG ATG CTT T Forward primer for internal fragment of 23s RNA gene 33
23s R AAA GGT ACT CTG GGG ATA A Reverse primer for internal fragment of 23s RNA gene 33
16s F AGA CAC GGC CCA GAC TCC TAC Forward primer for internal fragment of 16s RNA gene 33
16s R CAG TCA CCA ATG CAG TTC CCA Reverse primer for internal fragment of 16s RNA gene 33
bpsl2404F-173 GGC AAG GAT CTG CAA AAC GG Forward primer for amplification of bpsl2404 gene This study
bpsl2404R-173 ACG ACC GAC ACC TTC TTG TC Reverse primer for amplification of bpsl2404 gene This study
bpsl0337F-184 TCC CCA GTT CCT CCT CGA TT Forward primer for amplification of bpsl0337 gene This study
bpsl0337R-184 ATG CAA CAC ACC GAA CAA CC Reverse primer for amplification of bpsl0337 gene This study
bpss0068F-158 CTG CCG ATG CCG GAT TAT CA Forward primer for amplification of bpss0068 gene This study
bpss0068R-158 AAC GAA TTT GCT TGC TCG GG Reverse primer for amplification of bpss0068 gene This study
11
Vol.:(0123456789)
Scientific Reports |        (2020) 10:19242  | https://doi.org/10.1038/s41598-020-76186-z
www.nature.com/scientificreports/
 4. Willcocks, S. J., Denman, C. C., Atkins, H. S. & Wren, B. W. Intracellular replication of the well-armed pathogen Burkholderia 
pseudomallei. Curr. Opin. Microbiol. 29, 94–103 (2016).
 5. Holden, M. T. et al. Genomic plasticity of the causative agent of melioidosis, Burkholderia pseudomallei. Proc. Natl. Acad. Sci. USA 
101, 14240–14245 (2004).
 6. DeShazer, D., Brett, P. J., Burtnick, M. N. & Woods, D. E. Molecular characterization of genetic loci required for secretion of 
exoproducts in Burkholderia pseudomallei. J. Bacteriol. 181, 4661–4664 (1999).
 7. Raynaud, C. et al. Phospholipases C are involved in the virulence of Mycobacterium tuberculosis. Mol. Microbiol. 45, 203–217 
(2002).
 8. Ostroff, R. M., Wretlind, B. & Vasil, M. L. Mutations in the hemolytic-phospholipase C operon result in decreased virulence of 
Pseudomonas aeruginosa PAO1 grown under phosphate-limiting conditions. Infect. Immun. 57, 1369–1373 (1989).
 9. Awad, M. M., Bryant, A. E., Stevens, D. L. & Rood, J. I. Virulence studies on chromosomal alpha-toxin and theta-toxin mutants 
constructed by allelic exchange provide genetic evidence for the essential role of alpha-toxin in Clostridium perfringens-mediated 
gas gangrene. Mol. Microbiol. 15, 191–202 (1995).
 10. Camilli, A., Tilney, L. G. & Portnoy, D. A. Dual roles of plcA in Listeria monocytogenes pathogenesis. Mol. Microbiol. 8, 143–157 
(1993).
 11. Aurass, P. et al. The Legionella pneumophila Dot/Icm-secreted effector PlcC/CegC1 together with PlcA and PlcB promotes virulence 
and belongs to a novel zinc metallophospholipase C family present in bacteria and fungi. J. Biol. Chem. 288, 11080–11092 (2013).
 12. Flores-Diaz, M., Monturiol-Gross, L., Naylor, C., Alape-Giron, A. & Flieger, A. Bacterial sphingomyelinases and phospholipases 
as virulence factors. Microbiol. Mol. Biol. Rev. 80, 597–628 (2016).
 13. Kumari Bandana, K. J. Kaur Jagdeep Phospholipases in bacterial virulence and pathogenesis. Adv. Biotech. Micro. 10(5), 555798 
(2018).
 14. Korbsrisate, S. et al. Characterization of two distinct phospholipase C enzymes from Burkholderia pseudomallei. Microbiology 153, 
1907–1915 (2007).
 15. Burtnick, M. N., Brett, P. J. & DeShazer, D. Proteomic analysis of the Burkholderia pseudomallei type II secretome reveals hydrolytic 
enzymes, novel proteins, and the deubiquitinase TssM. Infect. Immun. 82, 3214–3226 (2014).
 16. Tuanyok, A., Tom, M., Dunbar, J. & Woods, D. E. Genome-wide expression analysis of Burkholderia pseudomallei infection in a 
hamster model of acute melioidosis. Infect. Immun. 74, 5465–5476 (2006).
 17. Dowling, A. J. et al. Genome-wide analysis reveals loci encoding anti-macrophage factors in the human pathogen Burkholderia 
pseudomallei K96243. PLoS ONE 5, e15693 (2010).
 18. Ooi, W. F. et al. The condition-dependent transcriptional landscape of Burkholderia pseudomallei. PLoS Genet. 9, e1003795 (2013).
 19. Bakala N’goma, J. C., Schue, M., Carriere, F., Geerlof, A. & Canaan, S. Evidence for the cytotoxic effects of Mycobacterium tuber-
culosis phospholipase C towards macrophages. Biochim. Biophys. Acta 1801, 1305–1313 (2010).
 20. Oda, M. et al. Signal transduction mechanism involved in Clostridium perfringens alpha-toxin-induced superoxide anion genera-
tion in rabbit neutrophils. Infect. Immun. 74, 2876–2886 (2006).
 21. Monturiol-Gross, L. et al. Internalization of Clostridium perfringens alpha-toxin leads to ERK activation and is involved on its 
cytotoxic effect. Cell Microbiol. 16, 535–547 (2014).
 22. Suparak, S. et al. Multinucleated giant cell formation and apoptosis in infected host cells is mediated by Burkholderia pseudomallei 
type III secretion protein BipB. J. Bacteriol. 187, 6556–6560 (2005).
 23. Srinon, V. et al. Comparative assessment of the intracellular survival of the Burkholderia pseudomallei bopC mutant. J. Microbiol. 
51, 522–526 (2013).
 24. Wand, M. E., Muller, C. M., Titball, R. W. & Michell, S. L. Macrophage and Galleria mellonella infection models reflect the virulence 
of naturally occurring isolates of B. pseudomallei, B. thailandensis and B. oklahomensis. BMC Microbiol. 11, 11 (2011).
 25. Tsai, C. J., Loh, J. M. & Proft, T. Galleria mellonella infection models for the study of bacterial diseases and for antimicrobial drug 
testing. Virulence 7, 214–229 (2016).
 26. Miao, J., Chard, L. S., Wang, Z. & Wang, Y. Syrian hamster as an animal model for the study on infectious diseases. Front. Immunol. 
10, 2329 (2019).
 27. Titball, R. W. et al. Burkholderia pseudomallei: animal models of infection. Trans. R. Soc. Trop. Med. Hyg. 102(Suppl 1), S111-116 
(2008).
 28. DeShazer, D., Brett, P. J., Carlyon, R. & Woods, D. E. Mutagenesis of Burkholderia pseudomallei with Tn5-OT182: isolation of 
motility mutants and molecular characterization of the flagellin structural gene. J. Bacteriol. 179, 2116–2125 (1997).
 29. Chua, K. L., Chan, Y. Y. & Gan, Y. H. Flagella are virulence determinants of Burkholderia pseudomallei. Infect. Immun. 71, 1622–
1629 (2003).
 30. Alexeyev, M. F. The pKNOCK series of broad-host-range mobilizable suicide vectors for gene knockout and targeted DNA inser-
tion into the chromosome of gram-negative bacteria. Biotechniques 26, 824–826 (1999).
 31. Muangsombut, V. et al. Inactivation of Burkholderia pseudomallei bsaQ results in decreased invasion efficiency and delayed escape 
of bacteria from endocytic vesicles. Arch. Microbiol. 190, 623–631 (2008).
 32. Pinweha, P. et al. Inactivation of bpsl1039-1040 ATP-binding cassette transporter reduces intracellular survival in macrophages, 
biofilm formation and virulence in the murine model of Burkholderia pseudomallei infection. PLoS ONE 13, e0196202 (2018).
 33. Muangsombut, V. et al. Burkholderia pseudomallei evades Nramp1 (Slc11a1)- and NADPH oxidase-mediated killing in mac-
rophages and exhibits Nramp1-dependent virulence gene expression. Front. Cell Infect. Microbiol. 7, 350 (2017).
Acknowledgements
The authors are grateful to Songprakhon P (Department of Research and Development, Siriraj Hospital) and 
Janesomboon S (Department of Immunology, Siriraj Hospital) for their kind technical assistances. Dr. Narisara 
Chantratita (Faculty of Tropical Medicine, Mahidol University, Thailand) for kindly provided mouse anti-Burk-
holderia monoclonal antibody. We used the laser scanning confocal microscope (LSM 800, Zeiss, Jena, Germany) 
at the Division of Molecular Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University.
Author contributions
Conceived and designed the experiments: V.S., S.K. Performed the experiments: V.S., P.W., S.C., M.T., C.M. 
Analyzed the data: V.S., P.W., S.K. Wrote the paper: V.S., P.W., J.M.S., R.W.T., S.K.
Funding
Korbsrisate S is supported by the Siriraj Grant for Research and Development, Faculty of Medicine Siriraj 
Hospital, Mahidol University. Meethai C is supported by the Royal Golden Jubilee Ph.D programme, Thailand 
Research Fund (PHD/0070/2559).
12
Vol:.(1234567890)
Scientific Reports |        (2020) 10:19242  | https://doi.org/10.1038/s41598-020-76186-z
www.nature.com/scientificreports/
Competing interests 
The authors declare no competing interests.
Additional information
Supplementary information  is available for this paper at https ://doi.org/10.1038/s4159 8-020-76186 -z.
Correspondence and requests for materials should be addressed to S.K.
Reprints and permissions information is available at www.nature.com/reprints.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and 
institutional affiliations.
Open Access  This article is licensed under a Creative Commons Attribution 4.0 International 
License, which permits use, sharing, adaptation, distribution and reproduction in any medium or 
format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the 
Creative Commons licence, and indicate if changes were made. The images or other third party material in this 
article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the 
material. If material is not included in the article’s Creative Commons licence and your intended use is not 
permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from 
the copyright holder. To view a copy of this licence, visit http://creat iveco mmons .org/licen ses/by/4.0/.
© The Author(s) 2020
